Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

被引:730
作者
Rolo, Anabela P. [2 ,3 ]
Teodoro, Joao S. [1 ,2 ]
Palmeira, Carlos M. [1 ,2 ]
机构
[1] Univ Coimbra, Dept Life Sci, Fac Sci & Technol, P-3004517 Coimbra, Portugal
[2] Univ Coimbra, Ctr Neurosci & Cell Biol, Fac Sci & Technol, P-3004517 Coimbra, Portugal
[3] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal
关键词
Cytokines; Fatty acids; Inflammation; Mitochondria; NASH; Oxidation; Oxidative stress; Free radicalss; FATTY LIVER-DISEASE; PROLIFERATOR-ACTIVATED RECEPTOR; MITOCHONDRIAL BETA-OXIDATION; REVERSE-TRANSCRIPTASE INHIBITORS; TUMOR-NECROSIS-FACTOR; TRANSFORMING-GROWTH-FACTOR; BINDING PROTEIN CHREBP; HUMAN SKELETAL-MUSCLE; NF-KAPPA-B; LIPID-PEROXIDATION;
D O I
10.1016/j.freeradbiomed.2011.10.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The worldwide rising prevalence of obesity and insulin resistance is associated with a parallel increase in nonalcoholic fatty liver disease (NAFLD). NAFLD is characterized by excess accumulation of triglyceride in the hepatocyte due to increased inflow of free fatty acids and/or de novo lipogenesis caused by various drugs and multiple defects in energy metabolism. Accumulation of lipids in the hepatocyte impairs the oxidative capacity of the mitochondria, increasing the reduced state of the electron transport chain (ETC) complexes and stimulating peroxisomal and microsomal pathways of fat oxidation. The consequent increased generation of reactive oxygen species (ROS) and reactive aldehydic derivatives causes oxidative stress and cell death, via ATP, NAD, and glutathione depletion and DNA, lipid, and protein damage. Oxidative stress also triggers production of inflammatory cytokines, causing inflammation and a fibrogenic response. This ultimately results in the development of nonalcoholic steatohepatitis (NASH), which can result in end-stage liver disease. The current therapeutic strategies for NASH treatment are mostly directed toward correction of the risk factors. Stimulation of mitochondrial function may also prevent NASH development, protecting the cell against the increased flux of reduced substrates to the ETC and ROS generation. (C) 2011 Elsevier Inc. All Fights reserved.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 217 条
[1]   Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice [J].
Aharoni-Simon, Michal ;
Hann-Obercyger, Michal ;
Pen, Svetlana ;
Madar, Zecharia ;
Tirosh, Oren .
LABORATORY INVESTIGATION, 2011, 91 (07) :1018-1028
[2]   Mitochondrial metabolism of reactive oxygen species [J].
Andreyev, AI ;
Kushnareva, YE ;
Starkov, AA .
BIOCHEMISTRY-MOSCOW, 2005, 70 (02) :200-214
[3]   Mouse models in non-alcoholic fatty liver disease and steatohepatitis research [J].
Anstee, QM ;
Goldin, RD .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2006, 87 (01) :1-16
[4]   Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease [J].
Araya, J ;
Rodrigo, R ;
Videla, LA ;
Thielemann, L ;
Orellana, M ;
Pettinelli, P ;
Poniachik, J .
CLINICAL SCIENCE, 2004, 106 (06) :635-643
[5]   Mitochondria in response to nutrients and nutrient-sensitive pathways [J].
Baltzer, Claudia ;
Tiefenbock, Stefanie K. ;
Frei, Christian .
MITOCHONDRION, 2010, 10 (06) :589-597
[6]   N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis [J].
Baumgardner, January N. ;
Shankar, Kartik ;
Hennings, Leah ;
Albano, Emanuele ;
Badger, Thomas M. ;
Ronis, Martin J. J. .
JOURNAL OF NUTRITION, 2008, 138 (10) :1872-1879
[7]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[8]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52
[9]   Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it [J].
Begriche, K ;
Igoudjil, A ;
Pessayre, D ;
Fromenty, B .
MITOCHONDRION, 2006, 6 (01) :1-28
[10]   ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [J].
Berg, AH ;
Combs, TP ;
Scherer, PE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :84-89